Guest Post: Eton Pharmaceuticals (ETON)
Eton Pharmaceuticals licensed rare-disease medicines, raised revenue guidance twice and climbed more than fourfold from its February 2026…
NASDAQ
Eton Pharmaceuticals, Inc.
ETON
1 article
$1.7B Market cap · 2026-09-01
